-
ORIGINAL RESEARCH
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
By Prakash S. Masand, MD, James Eudicone, MS, Andrei Pikalov, MD, PhD, Robert D. McQuade, PhD, Ronald N. Marcus, MD, Estelle Vester-Blokland, MD and Berit X. Carlson, PhD
-
NEGATIVE AND FAILED CLINICAL TRIAL RESULTS
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
By Andrew J. Cutler, Tram Tran-Johnson, Amir Kalali, Mikael Åström, Martin Brecher, Didier Meulien
-
A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder
By Ranran Li, Renrong Wu, Jun Chen, David E. Kemp, Ming Ren, Carla Conroy, Philip Chan, Mary Beth Serrano, Stephen J. Ganocy, Joseph R. Calabrese, Keming Gao